Lantern Pharma Inc.

NasdaqCM:LTRN Stock Report

Market Cap: US$33.7m

Lantern Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:LTRN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 May 24SellUS$57,789Bios Equity Partners LPCompany9,168US$6.33
24 May 24SellUS$131,311BIOS Fund II QP, LPCompany20,832US$6.33
29 Feb 24SellUS$206,528Bios Equity Partners LPCompany43,975US$4.87
29 Feb 24SellUS$469,766BIOS Fund II QP, LPCompany100,025US$4.87

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LTRN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders41,9270.389%
Public Companies631,1955.85%
Private Companies914,1258.48%
VC/PE Firms1,233,80211.4%
Institutions1,356,55612.6%
General Public6,607,12061.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 38.45% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Bios Equity Partners LP
1,233,802US$3.9m0%4.69%
8.48%
Biological Mimetics, Inc.
914,125US$2.9m0%no data
5.85%
ProPhase Labs, Inc.
631,195US$2.0m0%no data
3.37%
The Vanguard Group, Inc.
363,720US$1.1m0%no data
1.72%
CM Management, LLC
185,000US$578.1k131%0.5%
1.27%
NewEdge Advisors, LLC
137,338US$429.2k-12.6%no data
0.81%
Geode Capital Management, LLC
87,435US$273.2k1.26%no data
0.78%
Renaissance Technologies LLC
84,000US$262.5k2.69%no data
0.5%
Davenport Asset Management
53,814US$168.2k-15.7%no data
0.39%
Donald Keyser
41,927US$131.0k0%no data
0.38%
BlackRock, Inc.
40,480US$126.5k1.6%no data
0.36%
Redmond Asset Management, LLC
38,920US$121.6k-1.8%0.04%
0.35%
Dimensional Fund Advisors LP
37,548US$117.3k104%no data
0.32%
Two Sigma Investments, LP
34,340US$107.3k-1.26%no data
0.28%
Westside Investment Management, LLC
30,650US$95.8k167%0.02%
0.27%
Perigon Wealth Management, LLC, Asset Management Arm
28,900US$90.3k0%no data
0.27%
Sigma Planning Corporation
28,650US$89.5k0.88%no data
0.26%
Horizon Kinetics Holding Corporation
27,582US$86.2k-4.2%no data
0.25%
UBS Asset Management AG
26,871US$84.0k5.38%no data
0.25%
BNY Asset Management
26,482US$82.8k0%no data
0.22%
State Street Global Advisors, Inc.
23,652US$73.9k0%no data
0.2%
Susquehanna International Group, LLP, Asset Management Arm
21,881US$68.4k-63.4%no data
0.18%
Incrementum AG
18,888US$59.0k0%0.03%
0.16%
Tocqueville Asset Management LP
17,000US$53.1k0%no data
0.12%
Northern Trust Global Investments
12,813US$40.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 16:29
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lantern Pharma Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kyle BauserColliers Securities
Ashok KumarThinkEquity LLC
John VandermostenZacks Small-Cap Research